Latest News

View All Recent News »

Alimera Sciences To Release Fourth Quarter And Fiscal Year 2014 Financial Results

February 23, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its fourth quarter and fiscal year...

Read More »

Alimera Sciences To Present At 2015 Cowen Healthcare Conference

February 23, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth, Chief Operating Officer and Chief...

Read More »

Alimera Sciences To Host ILUVIEN® Live Webinar Launch Event

February 17, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced it will host a live webinar for eye care professionals on...

Read More »